Algert Global’s InflaRx IFRX Stock Holding History

Algert Global’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-23,010	Closed	-$68K	–	1042
2021 Q2	$68K	Sell	23,010 -11,630	-34%	-$38.6K	0.02%	406
2021 Q1	$135K	Buy	+34,640	New	+$177K	0.04%	395

Other funds holding IFRX

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Bank Julius Baer & Co

Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

Algert Global's IFRX Position: Q3 2021 in Review

Algert Global sold out of InflaRx (IFRX) in Q3 2021, closing a stake of 23,010 shares — an estimated $68K sold.

Algert Global first reported a position in IFRX in Q1 2021 and held it in 2 quarters. The position peaked at $135K in Q1 2021. 35 funds tracked by Wall St. Rank hold IFRX as of Q3 2021.

Algert Global reported no remaining InflaRx position as of Q3 2021 after selling out during the quarter.
Algert Global sold 23,010 InflaRx shares in Q3 2021, an estimated $68K.
Algert Global first reported a position in InflaRx in Q1 2021 and held it in 2 quarters.
Algert Global's InflaRx position peaked at $135K in Q1 2021.
35 funds tracked by Wall St. Rank held InflaRx as of Q3 2021.

Based on Algert Global's 13F filing for Q3 2021, filed 15 Nov 2021.